Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A2YNT30
Mon, 23.12.2024
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 23rd, 2024
3rd Interim Report
In the period from December 16th up to and including December 20th, 2024, a total of 9,277 shares of Alzchem Group AG were acquired as part of the sha [ … ]
Tue, 17.12.2024
Alzchem Group AG
Alzchem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Temporary Interruption of Share Repurchase Program
Alzchem Group AG temporarily interrupts its share repurchase program as published by announcement dated November 29, 2024 starting [ … ]
Mon, 16.12.2024
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 16th, 2024
2nd Interim Report
In the period from December 9th up to and including December 13th, 2024, a total of 13.964 shares of Alzchem Group AG were acquired as part of the sh [ … ]
Wed, 11.12.2024
Alzchem Group AG
Alzchem Group AG: Private placement of Alzchem shares by LIVIA Corporate Development SE and HDI Vier CE GmbH successfully completed
Trostberg, December 11, 2024 – Alzchem Group AG has been informed by its shareholders, LIVIA Corporate Development SE und HDI Vier CE GmbH, that the announced private placement of 250,000 shares (representing approxim [ … ]
Tue, 10.12.2024
Alzchem Group AG
Alzchem Group AG: LIVIA Corporate Development SE and HDI Vier CE GmbH inform about intended private placement of in total up to 250.000 Alzchem Group AG shares
Trostberg, December 10, 2024 – LIVIA Corporate Development SE and HDI Vier CE GmbH have informed Alzchem Group AG (ISIN DE000A2YNT30, WKN A2YNT3, Prime Standard) today that they intend to s [ … ]
Mon, 09.12.2024
Alzchem Group AG
Disclosure according to Article 5 of the EU Regulation 596/2014 and
Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Trostberg, December 9th, 2024
1st Interim Report
In the period from December 2nd up to and including December 6th, 2024, a total of 2,337 shares of Alzchem Group AG were acquired as part of the share [ … ]
Wed, 04.12.2024
Alzchem Group AG
Alzchem Group AG implements long-term succession planning for Management Board: Supervisory Board appoints Martina Spitzer as Chief Sales Officer effective January 1, 2025
Trostberg, December 4, 2024 – Alzchem Group AG, a globally active specialty chemicals company, is setting the course for continuous and sustainably successful development in Man [ … ]
Fri, 29.11.2024
Alzchem Group AG
Alzchem Group AG
Disclosure
according to Article 5 of the EU Regulation 596/2014
and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Share Repurchase
Alzchem Group AG announces the start of the share repurchase program which was published by an ad hoc announcement dated November 5, 2024.
Starting Dece [ … ]
Tue, 12.11.2024
Alzchem Group AG
EQS-Media / 12.11.2024 / 09:04 CET/CEST
Alzchem Group new partner of FC Bayern Basketball
Munich, November 12, 2024 – FC Bayern Basketball and Alzchem, a company based in Trostberg, have joined forces for the new season to achieve success together. With Alzchem's premium brand Creapure®, the internationally renowned manufacturer of creatine m [ … ]
Thu, 07.11.2024
Alzchem Group AG
Alzchem Group AG reports 36.4% EBITDA growth to EUR 76.8 million – strong earnings performance continues in the first nine months of 2024
Trostberg, November 7, 2024 – Alzchem Group AG, a globally active specialty chemicals company, continues its consistent transformation towards higher-margin specialty chemicals and was able to significantly incr [ … ]